SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (1968)7/9/1998 12:31:00 AM
From: Vector1  Respond to of 2553
 
Thanks Bob. I am still hanging in there with my GENZL share ownership. Burn victums go through tremendous pain and are at great risk of infection. It is nice to invest in a sector whose aim is to help people as well as make money.
V1



To: Machaon who wrote (1968)7/12/1998 1:11:00 PM
From: Linda Kaplan  Read Replies (2) | Respond to of 2553
 
Bob,

Can you explain the relationship between epicel and carticel?

I bought back the shares I traded off, by the way, at 5-1/4, on the 9th. They really just meet AIM's buy requirement for me, so I may hold them till AIM tells me to sell... unless I'm tempted again.

Linda


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News